87 results
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
will continue as a going concern and that contemplates the continuity of operations, the realization of assets and the satisfaction of liabilities
S-8
EX-4.2
PRTG
Portage Biotech Inc
1 Dec 23
Registration of securities for employees
4:05pm
, is earned or paid out upon the satisfaction of one or more performance goals will not be considered assumed if the Company or its successor modifies any
424B3
PRTG
Portage Biotech Inc
28 Nov 23
Prospectus supplement
4:03pm
will continue as a going concern and that contemplates the continuity of operations, the realization of assets and the satisfaction of liabilities
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Nov 23
Current report (foreign)
4:01pm
of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly, the accompanying
F-1
EX-5.1
t7c7oogtrpd4qz
31 Oct 23
Registration statement (foreign)
4:05pm
6-K
EX-4.3
g959o94ih5zdn415h152
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-10.1
y5vl6xlrkoi 66kr
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.1
5cmq44q
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-5.1
tsx7f4a270328if
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.2
6xzrlxwk
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.4
yisah45f
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.5
ca3xsobq7x3xe7oxx3k
3 Oct 23
Current report (foreign)
4:05pm
424B5
tejp16d okge0
2 Oct 23
Prospectus supplement for primary offering
6:01pm
6-K
EX-99.1
fcu 05kt4
29 Sep 23
Portage Biotech Announces $6.0 Million Registered Direct Offering
8:01am
6-K
EX-99.2
4zif6b4
29 Aug 23
Current report (foreign)
4:01pm